CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK90.69m
- SEK83.48m
- SEK17.49m
Brief: CLS Carries Out Compensation Issue In Connection With Completed Exercise Of Warrants
Brief: CLS Gets SEK 22.4 Mln Through Exercise Of Warrants, Decides On Directed Issue
Brief: CLS Gets Additional Guarantee Commitments Of About SEK 5.8 Mln For Warrants Of Series TO 7 B
Brief: Clinical Laserthermia Systems Q3 Loss After Financial Items Narrows To SEK 13.0 Mln
Brief: Cls Enters Subscription Undertakings
Brief: CLS To Streamline Ops, Focus On Neurosurgery Biz
Brief: Peter Max Is Proposed As New Chairman Of Clinical Laserthermia Systems
Brief: CLS Q2 Net Loss Narrows To SEK 13.6 Mln
Brief: CLS To Get SEK 38 Mln Through Rights Issue
Brief: CLS Enters The Italian Market For Focal Laser Ablation
Brief: CLS Receives Additional Order For Prism Products
Brief: ClS Resolves On A Partially Guaranteed Rights Issue Of About SEK 59 Mln
Brief: CLS Gets Second Order From National Institutes Of Health Clinical Center In US
Brief: CLS Signs Agreement With ROSE Urology
Brief: CLS Appoints Håkan Rosqvist As Interim CFO
Brief: Clinical Laserthermia Systems FY Basic EPS SEK -0.12
Brief: Clinical Laserthermia Systems Q4 Operating Loss Widens To SEK 20.41 Mln
Brief: CLS To Get About SEK 23.5 Mln In Connection With Warrant Exercise
Brief: Clinical Laserthermia Systems Files New Patent Application